Placental Lactogen Bovine Recombinant
Placental Lactogen Caprine Recombinant
Placental Lactogen Human Recombinant
Placental Lactogen Ovine Recombinant
Placental Lactogen Human Recombinant, Sf9
Sf9, Baculovirus cells.
Placental lactogen (PL), also known as chorionic somatomammotropin (CS), is a polypeptide hormone produced by the placenta during pregnancy. It belongs to the somatotropin family, which includes growth hormone (GH) and prolactin (PRL) . Human placental lactogen (hPL) is the specific form found in humans .
Key Biological Properties: hPL shares significant homology with human growth hormone (hGH) and human prolactin (hPRL) . It is a protein hormone with a molecular mass of approximately 22,125 Da, consisting of a single chain of 191 amino acids linked by two disulfide bonds .
Expression Patterns: hPL is synthesized and secreted by the syncytiotrophoblast cells of the placenta . Its levels increase progressively throughout pregnancy, peaking near term .
Tissue Distribution: hPL is primarily found in the placenta and maternal serum during pregnancy .
Primary Biological Functions: hPL plays a crucial role in regulating maternal metabolism to ensure an adequate supply of nutrients to the fetus . It promotes lipolysis, leading to increased free fatty acids for maternal energy use, while sparing glucose for fetal use . hPL also stimulates mammary gland development in preparation for lactation .
Role in Immune Responses and Pathogen Recognition: While hPL’s primary functions are metabolic and lactogenic, it may also have immunomodulatory effects, although this area requires further research .
Mechanisms with Other Molecules and Cells: hPL interacts with prolactin receptors and, to a lesser extent, growth hormone receptors . It mimics the actions of prolactin in various tissues, including the mammary glands .
Binding Partners and Downstream Signaling Cascades: hPL binds to prolactin receptors with high affinity, activating downstream signaling pathways that promote mammary gland development and metabolic adaptations .
Regulatory Mechanisms: The expression of hPL is tightly regulated at both the transcriptional and post-transcriptional levels . Transcriptional regulation involves various nuclear hormone receptors and cytokines that activate the hPL promoter . Post-translational modifications, such as glycosylation, may also play a role in hPL’s stability and activity .
Biomedical Research: hPL is used as a marker for placental function and fetal well-being in pregnancy . It is also studied for its role in metabolic adaptations during pregnancy and its potential implications in gestational diabetes .
Diagnostic Tools: Measurement of hPL levels in maternal serum can help assess placental function and detect potential complications such as placental insufficiency .
Therapeutic Strategies: While not directly used as a therapeutic agent, understanding hPL’s role in pregnancy can inform strategies to manage gestational diabetes and other metabolic disorders .
Role Throughout the Life Cycle: hPL is exclusively produced during pregnancy, with its levels rising in correlation with fetal and placental growth . It plays a vital role in fetal development by ensuring an adequate nutrient supply and preparing the maternal body for lactation . After childbirth, hPL levels rapidly decline .